Literature DB >> 15629601

Malignant parotid tumors: presentation, clinical/pathologic prognostic factors, and treatment outcomes.

Surjeet Pohar1, Hiram Gay, Paula Rosenbaum, Darren Klish, Jeffrey Bogart, Robert Sagerman, Jack Hsu, Robert Kellman.   

Abstract

PURPOSE: To determine the important clinical/pathologic prognostic factors and optimal treatment of malignant parotid tumors. METHODS AND MATERIALS: This study was a retrospective chart review of 163 patients treated for malignant parotid tumors at two institutions. Of the 163 patients, 91 were treated with surgical resection and radiotherapy (RT), 56 were treated with surgery alone, and 13 were treated with RT alone. The median follow-up was 5.1 years (range, 0-37 years).
RESULTS: Locoregional recurrence occurred in 37% of surgery-only, 11% of surgery plus RT, and 15% of RT-only patients (p = 0.001, Pearson's chi-square test). Cox proportional hazard multivariate analysis revealed that increasing age and higher stage were each statistically significantly (p < 0.05) associated with a poorer overall 5-year survival and cause-specific survival. Only increasing age and the absence of adjuvant RT were shown in Cox proportional hazard multivariate analysis to impact negatively on local failure-free survival.
CONCLUSION: In Cox proportional hazards multivariate analysis, only increasing age and stage were statistically significant prognostic factors for survival. The addition of RT to surgery did not improve overall survival but did reduce locoregional recurrence and improve local failure-free survival.

Entities:  

Mesh:

Year:  2005        PMID: 15629601     DOI: 10.1016/j.ijrobp.2004.04.052

Source DB:  PubMed          Journal:  Int J Radiat Oncol Biol Phys        ISSN: 0360-3016            Impact factor:   7.038


  19 in total

1.  Results of surgery plus postoperative radiotherapy for patients with malignant parotid tumor.

Authors:  Shogo Matsuda; Hiroyoshi Iguchi; Takuhito Tada; Masako Hosono; Masahiko Osawa; Yuuko Kuwae; Hideyuki Morimoto; Eiichiro Okazaki; Kosuke Amano; Yoshitaka Miki; Shinichi Tsutsumi; Yasuhiko Shimatani; Yukio Miki
Journal:  Jpn J Radiol       Date:  2015-07-10       Impact factor: 2.374

2.  Outcomes and prognostic factors in modern era management of major salivary gland cancer.

Authors:  Naresh Jegadeesh; Yuan Liu; Roshan S Prabhu; Kelly R Magliocca; David M Marcus; Kristin A Higgins; Jeffrey M Vainshtein; J Trad Wadsworth; Jonathan J Beitler
Journal:  Oral Oncol       Date:  2015-05-29       Impact factor: 5.337

3.  Analysis of prognostic risk factors and treatment of parotid cancer.

Authors:  Jinbiao Shang; Yingjie Wu; Wendong Wang; Kejing Wang; Minghua Ge
Journal:  Oncol Lett       Date:  2012-04-02       Impact factor: 2.967

4.  Oncological outcomes of patients with salivary gland cancer treated with surgery and postoperative intensity-modulated radiotherapy: a retrospective cohort study.

Authors:  Shoumei Zang; Meiqin Chen; Huijie Huang; Xinli Zhu; Xinke Li; Danfang Yan; Senxiang Yan
Journal:  Quant Imaging Med Surg       Date:  2022-05

5.  Salivary gland carcinoma in Denmark: a national update and follow-up on incidence, histology, and outcome.

Authors:  Marie Westergaard-Nielsen; Christian Godballe; Jesper Grau Eriksen; Stine Rosenkilde Larsen; Katalin Kiss; Tina Agander; Benedicte Parm Ulhøi; Birgitte Charabi; Tejs Ehlers Klug; Henrik Jacobsen; Jørgen Johansen; Claus Andrup Kristensen; Elo Andersen; Maria Andersen; Simon Andreasen; Kristine Bjørndal
Journal:  Eur Arch Otorhinolaryngol       Date:  2020-07-20       Impact factor: 2.503

6.  Primary and non-primary parotid malignancies: comparison of treatment modalities and outcomes.

Authors:  Sylvain Morinière; Sophie Périé; Jean Lacau St Guily
Journal:  Eur Arch Otorhinolaryngol       Date:  2007-05-30       Impact factor: 2.503

7.  Facial nerve function after parotidectomy for neoplasms with deep localization.

Authors:  Maurizio Marchesi; Marco Biffoni; Stefano Trinchi; Valeria Turriziani; Francesco Paolo Campana
Journal:  Surg Today       Date:  2006       Impact factor: 2.549

8.  Clinicopathological Behavior and Oncological Outcomes of Malignant Parotid Tumors in a Pakistani Population.

Authors:  Muhammad Faisal; Taskheer Abbas; Mohammad Adeel; Usman Khaleeq; Abdul Wahid Anwer; Kashif Malik; Raza Hussain; Arif Jamshed
Journal:  Cureus       Date:  2018-02-05

9.  Are all prognostic factors in parotid gland carcinoma well recognized?

Authors:  Dominik Stodulski; Boguslaw Mikaszewski; Czeslaw Stankiewicz
Journal:  Eur Arch Otorhinolaryngol       Date:  2011-08-06       Impact factor: 2.503

10.  Effect of clinical symptoms on the indication for selective neck dissection for N0 carcinomas of the parotid gland.

Authors:  Takashi Maruo; Yasushi Fujimoto; Kenji Yoshida; Mariko Hiramatsu; Atsushi Suzuki; Naoki Nishio; Mariko Shimono; Tsutomu Nakashima
Journal:  Oncol Lett       Date:  2014-05-12       Impact factor: 2.967

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.